BANNER
DEAD

Serial Number

78263135

Owner

BANNER LIFE SCIENCES LLC

Attorney

Maury M. Tepper, III

Filing Date

Jun 17, 2003

Add to watchlist:

No watchlists yet
View on USPTO

BANNER Trademark

Serial Number: 78263135 • Registration: 2962023

BANNER is a trademark filed by BANNER LIFE SCIENCES LLC on June 17, 2003. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

BANNER LIFE SCIENCES LLC (25 trademarks)

4125 PREMIER DRIVE
HIGH POINT, NC 27265

Entity Type: 16

BANNER PHARMACAPS INC. (60 trademarks)

Suite 301, 4100 Mendenhall Oaks Parkway
High Point, NC 272658034

Entity Type: 03

Banner Pharmacaps B.V. (2 trademarks)

NCB-weg 10, 5681
RH Best , NL

Entity Type: 03

Trademark Details

Filing Date

June 17, 2003

Registration Date

June 14, 2005

Published for Opposition

March 22, 2005

Cancellation Date

January 2, 2026

Goods & Services

Soft gelatin and non-animal film encapsulations and hard core enrobements of various pharmaceutical products, namely, [ AIDS related complex (ARC) therapeutic agents; ] antidiarrheals; antihistamines; analgesics; [ antacids; ] antiflatulents; [ antifungals; ] antiemetics; antipyretics; antiarthritics; [ antiinfectives for the treatment of fungal and viral infections; ] antinauseants; [ antiobesity; blood growth factor products; cancer therapy products; calcium supplements; cardiovascular agents, namely, calcium channel blockers for heart disease; ] cough and cold preparations; [ digestants; diuretics; dermatologicals for the treatment of skin disorders; ] gastrointestinal products, namely, preparations for the treatment of flatulence and constipation; [ hormones; ] histamine H2 receptor antagonists; hypnotics; hypolipidemics; laxatives; musculoskeletal products, namely, [ calcium, ] vitamin D and osteoporosis treatments; psychotherapeutics; pharmaceutical preparations for the treatment of disorders of the central nervous system; pharmaceutical preparations for the treatment of neurological disorders; drugs for the treatment of respiratory disorders; sedatives; [ drugs for the treatment of seizure disorders; ] sleep aids; [ drugs for the treatment of sexual dysfunction; ] transplant and immunosuppressant products, namely, cyclosporine; [ pharmaceutical preparations for the treatment of vascular disorders; ] soft gelatin and non-animal film encapsulations and hard core enrobements of natural medicine products, namely, [ a full line of ] herbal supplements; vitamin and mineral supplements and nutritional supplements, namely, [ a full line of ] vitamin and mineral supplements, nutritional supplements and herbal products; Pharmaceutical preparations, namely, [ AIDS related complex (ARC) therapeutic agents; ] antidiarrheals; antihistamines; analgesics; [ antacids; ] antiflatulents; [ antifungals; ] antiemetics; antipyretics; antiarthritics; [ antiinfectives for the treatment of fungal and viral infections; ] antinauseants; [ antiobesity; blood growth factor products; cancer therapy products; calcium supplements; cardiovascular agents, namely, calcium channel blockers for heart disease; ] cough and cold preparations; [ digestants; diuretics; dermatologicals for the treatment of skin disorders; ] gastrointestinal products, namely, preparations for the treatment of flatulence and constipation; [ hormones; ] histamine H2 receptor antagonists; hypnotics; hypolipidemics; laxatives; musculoskeletal products, namely, [ calcium, ] vitamin D and osteoporosis treatments; psychotherapeutics; pharmaceutical preparations for the treatment of disorders of the central nervous system; pharmaceutical preparations for the treatment of neurological disorders; drugs for the treatment of respiratory disorders; sedatives; drugs for the treatment of seizure disorders; sleep aids; [ drugs for the treatment of sexual dysfunction; ] transplant and immunosuppressant products, namely, cyclosporine; [ pharmaceutical preparations for the treatment of vascular disorders; ] soft gelatin and non-animal film encapsulations and hard core enrobements of natural medicine products, namely, [ a full line of ] herbal supplements; vitamin and mineral supplements and nutritional supplements, namely, [ a full line of ] vitamin and mineral supplements, nutritional supplements and herbal products

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Jan 2, 2026 CAEX
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jun 14, 2024 REM2
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Aug 5, 2015 ASCK
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Jun 13, 2015 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Jun 13, 2015 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Jun 13, 2015 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 13, 2015 APRE
TEAS SECTION 8 & 9 RECEIVED
May 26, 2015 E89R
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 31, 2014 TCCA
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Dec 24, 2014 ASGN
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Apr 30, 2014 ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Dec 26, 2012 ASCK
REGISTERED - SEC. 7 REQUEST ABANDONED
Jul 25, 2011 PRA7
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 21, 2011 APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 13, 2011 APRE
TEAS SECTION 7 REQUEST RECEIVED
Jul 6, 2011 ES7R
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Feb 3, 2011 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 3, 2011 APRE
TEAS SECTION 8 & 15 RECEIVED
Jan 21, 2011 E815
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 11, 2009 TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 11, 2009 TCCA
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
May 17, 2006 ASGN
REGISTERED-PRINCIPAL REGISTER
Jun 14, 2005 R.PR
PUBLISHED FOR OPPOSITION
Mar 22, 2005 PUBO
NOTICE OF PUBLICATION
Mar 2, 2005 NPUB
CASE FILE IN TICRS
Sep 29, 2004 CFIT
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 17, 2004 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 27, 2004 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 25, 2004 XAEC
ASSIGNED TO LIE
Aug 25, 2004 ALIE
EXAMINERS AMENDMENT E-MAILED
Aug 25, 2004 GNEA
Sec. 1(B) CLAIM DELETED
Aug 24, 2004 1.BD
AMENDMENT FROM APPLICANT ENTERED
Aug 12, 2004 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 4, 2004 CRFA
PAPER RECEIVED
Aug 4, 2004 MAIL
LETTER OF SUSPENSION E-MAILED
Jun 25, 2004 GNSL
PAPER RECEIVED
May 26, 2004 MAIL
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 25, 2004 CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 25, 2004 CRFA
NON-FINAL ACTION E-MAILED
Nov 25, 2003 GNRT
ASSIGNED TO EXAMINER
Nov 25, 2003 DOCK